Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Topline data from phase III PATENCY-1 study of investigational vonapanitase in patients with CKD

Dec. 14, 2016

Blisibimod BRIGHT-SC study demonstrates positive trends in the week 48 analysis

Dec. 9, 2016

Regulus unveils new drug development candidates

Dec. 9, 2016

Anti-APRIL monoclonal antibody developed at Visterra for IgA nephropathy

Dec. 7, 2016

Pharmalink's Nefecon earns orphan drug designation in E.U. for IgAN

Nov. 30, 2016

MonoSol files NDA with FDA for Tadalafil PharmFilm in the treatment of erectile dysfunction

Nov. 29, 2016

Enrollment completed in phase IIa study of Serodus' SER-150

Nov. 28, 2016

RGC upregulation may have a pathogenic role in lupus nephritis

Nov. 24, 2016

Rayaldee set for U.S. launch

Nov. 24, 2016

LPA receptor 1 as a target for diabetic nephropathy

Nov. 24, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...